Pharmaceutical Published Insights

Published Date : 02 Apr, 2026

The Global Lucentis Market is estimated to be valued at USD 739.1 Mn in 2025 and is expected to reach USD 64.1 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of -29.5% from 2025 to 2032. The global Lucent... View more

Published Date : 02 Apr, 2026

The Global Remicade Market is estimated to be valued at USD 1,422.0 Mn in 2025 and is expected to reach USD 655.0 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of -10.48% from 2025 to 2032. Despite the prevalence of autoimmune diseases such as rheumatoid... View more

Published Date : 02 Apr, 2026

The Global Loperamide Hydrochloride Market is estimated to be valued at USD 3.52 bn in 2025 and is expected to reach USD 5.21 bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.75% from 2025 to 2032. The... View more

Published Date : 02 Apr, 2026

The Global Eye Drops Market is estimated to be valued at USD 6.81 Bn in 2025 and is expected to reach USD 9.27 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 4.2% from 2025 to 2032. Th... View more

Published Date : 02 Apr, 2026

The Global Melatonin Sleep Gummy Market is estimated to be valued at USD 365.4 Mn in 2025 and is expected to reach USD 642.6 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.4% from 20... View more

Published Date : 02 Apr, 2026

The global Neupogen market, while initially experiencing growth, is now facing a decline due to several factors. Neupogen (filgrastim) is a recombinant human granulocyte colony-stimulating factor (G-CSF) that stimulates the production of neutrophils, which are essenti... View more

Published Date : 02 Apr, 2026

The Global Xgeva Market is estimated to be valued at USD 2,501.1 Million in 2025 and is expected to reach USD 3,140.7 Million by 2032, exhibiting a compound annual growth rate (CAGR) of 2.7% from 2025 to 2032. The global Xgeva market represents a critical segment with... View more

Published Date : 02 Apr, 2026

The global hereditary spastic paraplegia market is estimated to be valued at USD Mn 181.4 Mn in 2025 and is expected to reach USD Mn 456.8 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.2% from 2025 ... View more

Published Date : 02 Apr, 2026

The Global Polidocanol Injection Market is estimated to be valued at USD 92.7 million in 2025 and is expected to reach USD 154.8 million by 2032, exhibiting a compound annual growth rate (CAGR) of 7.6% from 2025 to 20... View more

Published Date : 02 Apr, 2026

The Global Liraglutide Market is estimated to be valued at USD 2.38 Bn in 2025 and is expected to decline to USD 1.58 Bn by 2032, exhibiting a negative compound annual growth rate (CAGR) of -5.6% from 2025 to 2032.... View more

Published Date : 02 Apr, 2026

The Global Topical Analgesic Market is estimated to be valued at USD 12.10 Bn in 2025 and is expected to reach USD 18.56 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.3% from 2025 t... View more

Published Date : 02 Apr, 2026

The Global Antiseptic Mouthwash Market is estimated to be valued at USD 3.12 Bn in 2025 and is expected to reach USD 6.64 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.4% from 2025... View more

Published Date : 02 Apr, 2026

The Global Axial Spondyloarthritis Market is estimated to be valued at USD 4.41 Bn in 2025 and is expected to reach USD 7.01 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.85% from 2025 to 2032. ... View more

Published Date : 02 Apr, 2026

The Global ENTRESTO Market is estimated to be valued at USD 9.09 Bn in 2025 and is expected to reach USD 12.21 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 4.3% from 2025 to 2032. Th... View more

Published Date : 02 Apr, 2026

The global Victoza market is estimated to be valued at USD 647.3 Mn in 2025 and is expected to decline to USD 172.6 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of -17.2% from 2025 to 2... View more

Published Date : 02 Apr, 2026

The Global Zoledronic Acid Market is estimated to be valued at USD 5.38 Bn in 2025 and is expected to reach USD 7.62 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.1% from 2025 to 20... View more

Published Date : 02 Apr, 2026

The Global Xolair Market, which is expected to be valued at approximately USD 4,049.1 Mn in 2025 is projected to decline to USD 2,269.4 Mn by 2032, reflecting a compound annual growth rate (CAGR) of -7.9%... View more

Published Date : 02 Apr, 2026

The Global Imbruvica Market, valued at USD 3.02 Bn in 2025, is expected to decline to USD 1.41 Bn by 2032, reflecting a compound annual growth rate (CAGR) of -10.3% from 2025 to 2032. Despite its stro... View more